Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge

被引:22
作者
Vecino, WH
Quanquin, NM
Martinez-Sobrido, L
Fernandez-Sesma, A
García-Sastre, A
Jacobs, WR
Fennelly, GJ [1 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Pediat, Ullman Room 121,1300 Morris Pk Ave, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[3] CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA
[4] Jacobi Med Ctr, Lewis M Fraad Dept Pediat, Bronx, NY 10461 USA
关键词
influenza virus; hemagglutinin; attenuated shigella; bacterial vector; DNA vaccines; IFN-gamma; mucosal immunity; pandemic; T cell;
D O I
10.1016/j.virol.2004.04.045
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Mucosal surfaces are important for the induction of immunity against influenza virus. In a murine intranasal immunization model, we demonstrated that the attenuated Shigella flexneri Deltaasd strain 15D, carrying a DNA construct encoding the influenza virus hemagglutinin (HA), induces protective immunity against a lethal respiratory challenge with influenza A/WSN/33. Influenza virus-specific IFN-gamma T cells were detected among splenocytes, and anti-HA IgG was detected in serum post-immunization, albeit at low levels. Following influenza virus challenge, an accelerated anti-HA IgA antibody response was detected in bronchoalveolar lavage (BAL) washings from mice vaccinated with attenuated shigella containing the HA construct. These results suggest that S. flexneri Deltaasd strain 15D is a promising vector for mucosal DNA vaccine immunization against influenza virus and other mucosal pathogens. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 42 条
[1]
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes [J].
Boon, ACM ;
de Mutsert, G ;
van Baarle, D ;
Smith, DJ ;
Lapedes, AS ;
Fouchier, RAM ;
Sintnicolaas, K ;
Osterhaus, ADME ;
Rimmelzwaan, GF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2453-2460
[2]
Protective role of gamma interferon during the recall response to influenza virus [J].
Bot, A ;
Bot, S ;
Bona, CA .
JOURNAL OF VIROLOGY, 1998, 72 (08) :6637-6645
[3]
Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene [J].
Bot, A ;
Antohi, S ;
Bot, S ;
GarciaSastre, A ;
Bona, C .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (11) :1641-1650
[4]
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5HA vaccine [J].
Bright, RA ;
Ross, TM ;
Subbarao, K ;
Robinson, HL ;
Katz, JM .
VIROLOGY, 2003, 308 (02) :270-278
[5]
*CDC, 2003, MMWR-MORBID MORTAL W, V52, P1232
[6]
Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate [J].
Chen, H ;
Matsuoka, Y ;
Swayne, D ;
Chen, Q ;
Cox, NJ ;
Murphy, BR ;
Subbarao, K .
VACCINE, 2003, 21 (27-30) :4430-4436
[7]
CELL-MEDIATED IMMUNE-RESPONSES TO THE HEMAGGLUTININ AND NEURAMINIDASE ANTIGENS OF INFLUENZA-A VIRUS AFTER IMMUNIZATION IN HUMANS [J].
CHOW, TC ;
BEUTNER, KR ;
OGRA, PL .
INFECTION AND IMMUNITY, 1979, 25 (01) :103-109
[8]
Courvalin P, 1995, CR ACAD SCI III-VIE, V318, P1207
[9]
DEMICHELI V, 2000, COCHRANE DATABASE SY
[10]
Fennelly GJ, 1999, J IMMUNOL, V162, P1603